Thèse D.GATEFF

80
SECHI GB, AGNETTI V, PIREDDA M et coll. Acute and persistent parkinsonism after use of diquat.
Neurology 1992 ; 42 : 261
81
SANCHEZ-RAMOS J, HEFTI F, WEINER W. Paraqsuat and Parkinson s disease. Neurology 1987 ; 37 : 728
82
BHATT MH, ELIAS MA, Mankodi AK. Acute and reversible parkinsonism due to organophosphate pesticide
intoxication five cases. Neurology 1999 ; 52 : 1467-1471
83
LAI BCL, MARION SA, TESCHKE K et coll. Occupational and environmental risk factors for Parkinson s
disease. Parkinsonism Rel Disord 2002 ; 8 : 297 309.
84
Nature Reviews Neuroscience 4; 365-375 (2003).
85
TANNER CM et al. Parkinson Disease in twins : an etiology study. JAMA. 1999 ; 281 : 341
86
ZAGNOLI F. Op. cit. P30
87
Ibid. P32
88
Ibid. P21
89
DEFEBVRE L, VERIN M. Op. cit. p45-62
90
DEFEBVRE L, VERIN M. Op. cit. p45
91
ZAGNOLI F Op. cit. P 20
92
Ibid. P 18
93
Ibid. P 21
94
Ibid. P 19
95
J. QUEVAUVILLIERS. Dictionnaire médical de poche. Paris Masson 2005. p15
96
KEMOUN G, DEFEBVRE L. Trouble de la marche dans la maladie de Parkinson. Press Med 2001 ; 30 : 443-
468
97 PETIT H, VERMERSCH P, PASQUIER F. Some clinical aspect of late onset Parkinsonism. Clin Neurol
Neurosurg 1992 ; 94 : 5137-5151
98 FRIEDMAN A. Old-onset Parkinson s disease compared with young-onset disease : clinical differences and
similarities. Acta Neurol Scand 1994 ; 89 : 258-261
99 HUISMAN E, UYLING HBM, HOOGLAND PV. A 100 % increase of dopaminergic cells in the olfactory
bulb may explain hyposmia in Parkinson s disease. Mov Disord 2004 ; 19 : 687-692
100 GERSCHLAGER W, MUNCHAU A, KATZENSCHLAGER R and coll. Natural history and syndromic
association of orthostatic tremor : a review of 41 patients. Mov Disord 2004 ; 19 : 788-295
101 OLSON EJ, BOEVE BF, SILBER MH. Rapid eye movement sleep behaviour disorder : demographic,
clinicaland laboratory finding in 93 cases. Brain 2000 ; 123 : 331-339
102 ZAGNOLI F. Op. cit. P 43
103
Ibid. P 170
104
MARSDEN CD, PARKES J, Fluctuations of disability in Parkinson s disease : clinical aspects. In
MARSDEN CD, FAHN S. Movement Disorders, Neurology 2. Butterworth, London, 1982 : 96-122.
105
DEFEBVRE L, VERIN M. Op. cit. p52.
106
QUINN NP.Classification of fluctuations in patientswith Parkinson s disease. Neurology 1998 ; 51 (suppl 2) :
S25-S29
107
METMAN LV, KONITSIOTIS S, CHASE TN,. Pathophysiology of motor reponse complications in
Parkinson s disease ; hypotheses on the only why, where and what. Mov Disord 2000 ; 15 : 3-8
108
DEFEBVRE L, VERIN M. Op. cit. p53
109
FERNANDEZ W, STERN G. Hallucinations in Parkinsonian motor fluctuations. Behav Neurol 1992 ; 5 : 83-
86
110 GIROTTI F, CARELLA F, GRASSI MP et coll. Motor and cognitive performance of parkinsonian patients in
the on and off phases of the disease. J Neurol Neurosurg Psychiatr 1986 ; 49 : 657-660
111 DERKINDEREN P, VIDAILHET M. Dyskinésies provoquées par la L-dopa. Rev Neurol 2002 ; 158 : 7S92-
7S101
112 DEFEBVRE L, VERIN M. Op. cit. p54.
113 Ibid. p55.
114 MUENTER MD. SHARPLESS NS, TYCE GM et coll. Patterns of dystonia (« I-D-I » and « D-I-D ») in
response to L-dopa therapy for Parkinson s disease. Mayo Clin. Proc 1997 ; 52 : 163-174.
115 DIETZ V, ZIJLSTRA W, ASSAIANTE C et coll. Balance control in Parkinson s disease. Gait Post 1993 ; 1 :
77-84.
116 DEFEBVRE L, VERIN M. Op. cit p63-77 et p144-147
117 POLLACK P, TRANCHANT C. Les autres symptomes de la phase évoluée de la Maladie de Parkinson. Rev
Neurol 2000 ; 156 : S2b 165-173
118 DEWEY RB. Autonomic dysfunctions in Parkinson s disease. Neurol Clin 2004 ; 22 : S127-S139
119 JOST WH Autonomic dysfunctions in idiopathic Parkinson s disease. J Neurol 2003 250 (suppl1) : 28-30
258